股票行情快报：五洲医疗（301234）11月7日主力资金净卖出261.04万元

Core Viewpoint - The stock of Wuzhou Medical (301234) has shown a decline in price and mixed capital flow, indicating potential challenges in market sentiment and financial performance [1][2]. Financial Performance - As of November 7, 2025, Wuzhou Medical's stock closed at 39.94 yuan, down 1.19% with a trading volume of 8,708 hands and a transaction value of 34.96 million yuan [1]. - In the third quarter of 2025, the company reported a main revenue of 128 million yuan, a year-on-year decrease of 1.51%, and a net profit attributable to shareholders of 7.99 million yuan, down 36.39% year-on-year [3]. - For the first three quarters of 2025, the company's main revenue was 345 million yuan, up 0.82% year-on-year, while the net profit decreased by 46.09% to 18.51 million yuan [3]. Capital Flow Analysis - On November 7, 2025, the net outflow of main funds was 2.61 million yuan, accounting for 7.47% of the total transaction value, while retail investors saw a net inflow of 2.69 million yuan, representing 7.68% of the total [1][2]. - Over the past five days, the stock has experienced fluctuating capital flows, with significant net outflows from main funds on November 6 and 7, indicating a bearish sentiment [2]. Industry Comparison - Wuzhou Medical's total market value is 2.716 billion yuan, significantly lower than the industry average of 11.464 billion yuan, ranking 111 out of 124 in the medical device industry [3]. - The company's net profit margin stands at 5.36%, below the industry average of 9.57%, and its gross margin is 14.22%, compared to the industry average of 51.22% [3].